QC
HELP

Quadrature Capital’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Quadrature Capital’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$309K Buy
+46,789
New +$234K ﹤0.01% 1191
2026
Q1 		– Sell
-79,697
Closed -$652K – 1462
2025
Q4 		$652K Buy
+79,697
New +$513K 0.01% 624

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

Quadrature Capital's HELP Position: Q2 2026 in Review

Quadrature Capital opened a new position in Helus Pharma Inc. Common Stock (HELP) in Q2 2026: 46,789 shares worth $309K. The stake represents ﹤0.01% of the portfolio and ranks #1191 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in HELP as recently as Q4 2025.

Quadrature Capital first reported a position in HELP in Q4 2025 and has held it in 2 quarters since. The position peaked at $652K in Q4 2025. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • Quadrature Capital held 46,789 shares of Helus Pharma Inc. Common Stock worth $309K as of Q2 2026.
  • Helus Pharma Inc. Common Stock was a new Quadrature Capital position in Q2 2026.
  • Helus Pharma Inc. Common Stock made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1191 holding.
  • Quadrature Capital first reported a position in Helus Pharma Inc. Common Stock in Q4 2025 and has held it in 2 quarters since.
  • Quadrature Capital's Helus Pharma Inc. Common Stock position peaked at $652K in Q4 2025.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.